Ketamine-assisted psychotherapy in adolescents with multiple psychiatric diagnoses
Bibliographic Data
| ID | 15523865 |
|---|---|
| Authors | Philip E Wolfson (0000-0003-0867-0861, Pine Street Foundation, corresponding author), Julane Andries (EnZinc (United States)), Daniel Ahlers (0000-0002-9751-626X, Pine Street Foundation), Melissa Whippo (EnZinc (United States)) |
| Year | 2023 |
| Volume | 14 |
| Pages | 1141988-1141988 |
| Publication date | 2023-03-30 |
| Peer Reviewed | Yes |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | Frontiers in Psychiatry (JOURNAL) |
| Journal identifiers | ISSN: 1664-0640 • E-ISSN: 1664-0640 |
| Publisher | Frontiers Media (PUBLISHER • CH) |
| DOI | 10.3389/fpsyt.2023.1141988 |
| PMID | 37065886 |
| OpenAlex | W4361272495 |
| Language | EN |
| Citations received | 3 |
| References cited | 60 |
Ketamine-assisted psychotherapy is a promising new treatment for a variety of mental disorders of adolescence. There is currently an adolescent mental health crisis, with a high prevalence of disorders, diagnostic complexity, and many adolescents failing to respond to conventional treatments. While there is strong evidence for the use of ketamine in adults for a variety of treatment-refractory mental illnesses, research in adolescents is in its early stages. Ketamine-assisted psychotherapy (KAP) has been described in adults with promising results and here we present the first published cases of the use of KAP in adolescents. The four cases include adolescents aged 14-19 at the initiation of treatment, each with a variety of comorbid diagnoses including treatment-resistant depression, bipolar disorder, eating disorders, anxiety, panic, and trauma-related symptoms. They each initially received sublingual ketamine, followed by sessions with intramuscular ketamine. Their courses varied, but each had symptomatic and functional improvements, and the treatment was well-tolerated. Subjective patient reports are included. Rapid resolution of symptomatology and suffering often occurs within months as the result of the application of KAP to adolescent psychiatric care but is not inevitable. Family involvement in the treatment process appears to be essential to success. The development of this modality may have a singularly positive impact that will expand the psychiatric toolbox and its healing potency
Anxiety · Depression (economics · Ketamine · Mental health · Panic disorder · Psychiatry · Bipolar Disorder and Treatment · Clinical Psychology · Medicine · Psychology · Treatment of Major Depression · Tryptophan and brain disorders
Mood disorders in children and adolescents
Emergency Department Visits for Suspected Suicide Attempts Among Persons Aged 12–25 Years Before and During the Covid-19 Pandemic — United States, January 2019–May 2021
Prevalence and Treatment of Depression, Anxiety, and Conduct Problems in US Children
Adolescent identity development in context
Prevalence, Correlates, and Treatment of Lifetime Suicidal Behavior Among Adolescents
The safety and efficacy of ±3,4-methylenedioxymethamphetamine-assisted psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder
Global Prevalence of Depressive and Anxiety Symptoms in Children and Adolescents During Covid-19
Constructing drug effects
Adolescent suicide and suicidal behavior
Annual Research Review
Safety, effectiveness and tolerability of sublingual ketamine in depression and anxiety
Ketamine Assisted Psychotherapy (KAP)
| Unique citing works | 3 |
|---|---|
| Citations per year | 1 |
| Citation span | 2023 - 2026 (4) |
| Citation velocity | current |
| Highly cited | No |
| Citation types | Neutral: 3 |